Doug is a native South Floridian. He holds an MS in Biotechnology from Georgetown University and a BS in Biological Sciences from Florida State University. After graduating from Georgetown, Doug eventually went on to work in Biotech Investor Relations in New York City. From there, he moved back to his home town in South Florida to spearhead the expansion of a European Life Sciences Consultancy to the US.
Currently, he serves as an Investor Relations Manager for Graphite Bio, a next-generation gene editing company focused on developing therapies to cure serious, life-threatening genetic diseases and is also the Principal and Founder of Renegade BioConsulting, where he has helped numerous companies from Europe and Asia successfully enter the US market.